DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8<SUP>+</SUP> T cells
Yu Z, Sasidharan-Nair V, Buchta T, Bonifacius A, Khan F, Pietzsch B, Ahmadi H, Beckstette M, Niemz J, Hilgendorf P, Mausberg P, et al. (2024)
PLoS Pathogens 20(9): e1012581.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Yu, Zheng;
Sasidharan-Nair, Varun;
Buchta, Thalea;
Bonifacius, Agnes;
Khan, Fawad;
Pietzsch, Beate;
Ahmadi, Hosein;
Beckstette, MichaelUniBi;
Niemz, Jana;
Hilgendorf, Philipp;
Mausberg, Philip;
Keller, Andreas
Alle
Alle
Einrichtung
Abstract / Bemerkung
Epigenetic mechanisms stabilize gene expression patterns during CD8(+) T cell differentiation. Although adoptive transfer of virus-specific T cells is clinically applied to reduce the risk of virus infection or reactivation in immunocompromised individuals, the DNA methylation pattern of virus-specific CD8(+) T cells is largely unknown. Hence, we here performed whole-genome bisulfite sequencing of cytomegalovirus-specific human CD8(+) T cells and found that they display a unique DNA methylation pattern consisting of 79 differentially methylated regions (DMRs) when compared to memory CD8(+) T cells. Among the top demethylated DMRs in cytomegalovirus-specific CD8(+) T cells was TBKBP1, coding for TBK-binding protein 1 that can interact with TANK-binding kinase 1 (TBK1) and mediate pro-inflammatory responses in innate immune cells downstream of intracellular virus sensing. Since TBKBP1 has not yet been reported in T cells, we aimed to unravel its role in virus-specific CD8(+) T cells. TBKBP1 demethylation in terminal effector CD8(+) T cells correlated with higher TBKBP1 expression at both mRNA and protein level, independent of alternative splicing of TBKBP1 transcripts. Notably, the distinct DNA methylation patterns in CD8(+) T cell subsets was stable upon long-term in vitro culture. TBKBP1 overexpression resulted in enhanced TBK1 phosphorylation upon stimulation of CD8(+) T cells and significantly improved their virus neutralization capacity. Collectively, our data demonstrate that TBKBP1 modulates virus-specific CD8(+) T cell responses and could be exploited as therapeutic target to improve adoptive T cell therapies.
Erscheinungsjahr
2024
Zeitschriftentitel
PLoS Pathogens
Band
20
Ausgabe
9
Art.-Nr.
e1012581
ISSN
1553-7366
eISSN
1553-7374
Page URI
https://pub.uni-bielefeld.de/record/2993459
Zitieren
Yu Z, Sasidharan-Nair V, Buchta T, et al. DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8<SUP>+</SUP> T cells. PLoS Pathogens . 2024;20(9): e1012581.
Yu, Z., Sasidharan-Nair, V., Buchta, T., Bonifacius, A., Khan, F., Pietzsch, B., Ahmadi, H., et al. (2024). DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8<SUP>+</SUP> T cells. PLoS Pathogens , 20(9), e1012581. https://doi.org/10.1371/journal.ppat.1012581
Yu, Zheng, Sasidharan-Nair, Varun, Buchta, Thalea, Bonifacius, Agnes, Khan, Fawad, Pietzsch, Beate, Ahmadi, Hosein, et al. 2024. “DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8<SUP>+</SUP> T cells”. PLoS Pathogens 20 (9): e1012581.
Yu, Z., Sasidharan-Nair, V., Buchta, T., Bonifacius, A., Khan, F., Pietzsch, B., Ahmadi, H., Beckstette, M., Niemz, J., Hilgendorf, P., et al. (2024). DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8<SUP>+</SUP> T cells. PLoS Pathogens 20:e1012581.
Yu, Z., et al., 2024. DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8<SUP>+</SUP> T cells. PLoS Pathogens , 20(9): e1012581.
Z. Yu, et al., “DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8<SUP>+</SUP> T cells”, PLoS Pathogens , vol. 20, 2024, : e1012581.
Yu, Z., Sasidharan-Nair, V., Buchta, T., Bonifacius, A., Khan, F., Pietzsch, B., Ahmadi, H., Beckstette, M., Niemz, J., Hilgendorf, P., Mausberg, P., Keller, A., Falk, C., Busch, D.H., Schober, K., Cicin-Sain, L., Müller, F., Brinkmann, M.M., Eiz-Vesper, B., Floess, S., Huehn, J.: DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8<SUP>+</SUP> T cells. PLoS Pathogens . 20, : e1012581 (2024).
Yu, Zheng, Sasidharan-Nair, Varun, Buchta, Thalea, Bonifacius, Agnes, Khan, Fawad, Pietzsch, Beate, Ahmadi, Hosein, Beckstette, Michael, Niemz, Jana, Hilgendorf, Philipp, Mausberg, Philip, Keller, Andreas, Falk, Christine, Busch, Dirk H., Schober, Kilian, Cicin-Sain, Luka, Müller, Fabian, Brinkmann, Melanie M., Eiz-Vesper, Britta, Floess, Stefan, and Huehn, Jochen. “DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8<SUP>+</SUP> T cells”. PLoS Pathogens 20.9 (2024): e1012581.
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 39325839
PubMed | Europe PMC
Suchen in